Starlight Therapy in Palliative Care

N

Nova Scotia Health Authority (NSHA)

Status

Not yet enrolling

Conditions

Symptom Management

Treatments

Other: Starlight Therapy

Study type

Observational

Funder types

Other

Identifiers

NCT03716999
Starlight Trial

Details and patient eligibility

About

Starlight Therapy™ has been shown to help alleviate end-of-life symptoms in Palliative Care patients and reduce the need for PRN or "as needed" medications. This study will investigate the efficacy of this intervention on the symptom of anxiety using a mixed-method analysis. The primary investigator hypothesizes that any anti-anxiolytic effects could be caused by the Intrinsically Photosensitive Retinal Ganglion Cell neural pathway to the amygdala.

Full description

Starlight Therapy has been shown (see citation) to help alleviate end-of-life symptoms in Palliative Care patients and reduce the need for PRN or "as needed" medications. This study will investigate the efficacy of this intervention using a mixed-method analysis. Starlight Therapy will be offered to patients with unpleasant end-of-life symptoms such as dyspnea, agitation, anxiety, restlessness and insomnia. The effect the Starlight Therapy has in helping alleviate these symptoms will be measured using the ESAS (Edmonton Symptom Assessment System) questionnaire at baseline and following a predetermined period of time of Starlight Therapy. 10 Starlight Projectors have been purchased for the unit where the study will take place: the Inpatient Palliative Care Unit 7A, Victoria General Hospital, Centennial Building. The funding was acquired by a Comfort & Care Grant from the QEII Foundation. The results will be compiled and analyzed in a research paper "Concerning the Efficacy and Underlying Mechanism of Starlight Therapy as a Non-Pharmacological Nursing Intervention for Palliative Care Patients".

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

1. ESAS indicates at least one of the following symptoms:

  • Insomnia
  • Anxiety
  • Restlessness
  • Dyspnea
  • Pain

Exclusion criteria

Clinical Diagnosis of blindness

ESAS does not include any of the flowing symptoms:

  • Insomnia
  • Anxiety
  • Restlessness
  • Dyspnea
  • Pain

Trial design

100 participants in 1 patient group

Palliative Care Patients
Description:
Palliative care Patients meeting criteria will receive Starlight Therapy
Treatment:
Other: Starlight Therapy

Trial contacts and locations

0

Loading...

Central trial contact

shelley A sandblom, BA, BScN, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems